Physician

Katherine Chiyu Wang, MD, PHD

According to 2025 Medicare claims, Katherine Wang, MD, PHD (NPI: 1669494134) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75231-7001. Wang is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 611 traditional Medicare patients, billed 145,787 HCPCS/CPT codes, and received $2,231,739 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,286 prescription claims across 186 beneficiaries totaling $4,382,178 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 24 claims. Open Payments data shows 97 records totaling $31,604. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $509,398 to $4,382,178. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	327	104,183	$1,293,877
2016	563	115,959	$1,779,697
2017	636	125,953	$1,890,216
2018	660	122,001	$2,010,842
2019	652	158,748	$2,175,771
2020	588	126,792	$1,676,114
2021	589	134,119	$1,689,703
2022	593	119,565	$1,964,904
2023	584	132,123	$1,812,897
2024	611	145,787	$2,231,739

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	126	748	$509,398
2016	143	983	$837,945
2017	133	909	$1,392,306
2018	152	1,122	$2,033,961
2019	143	1,310	$2,388,844
2020	160	1,100	$2,218,848
2021	161	1,050	$2,297,839
2022	160	1,066	$2,884,278
2023	162	1,164	$3,266,287
2024	186	1,286	$4,382,178

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	130	$32,852
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	37	$2,938
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$1,039

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	147	331	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	420	$92
80053	Blood test, comprehensive group of blood chemicals	267	839	$10
36415	Insertion of needle into vein for collection of blood sample	270	984	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	263	898	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	36	1,080	$458,998
Pomalyst	Pomalidomide	18	504	$418,985
Jakafi	Ruxolitinib Phosphate	33	1,050	$412,112
Tagrisso	Osimertinib Mesylate	23	720	$378,987
Ibrance	Palbociclib	23	666	$338,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$854
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$185

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$31,604	Immunocore Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Katherine Chiyu Wang, MD, PHD?

Tedicare shows public-source Medicare data for Katherine Chiyu Wang, MD, PHD (NPI 1669494134), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Katherine Chiyu Wang, MD, PHD have ACO affiliation data?

Katherine Chiyu Wang, MD, PHD is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Katherine Chiyu Wang, MD, PHD?

Katherine Chiyu Wang, MD, PHD is linked to TEXAS ONCOLOGY PA (billing NPI 1003083445) in the available physician profile data.

Does Katherine Chiyu Wang, MD, PHD have Open Payments data?

Katherine Chiyu Wang, MD, PHD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.